비피도박테리움 롱검 관련 과민성 대장 증후군(IBS)

References

1. [1] Theodore Rokkas et al.. Eur J Gastroenterol Hepatol. 2026. Comparative effectiveness and safety of probiotics with psychotropic potential in mental health benefits in irritable bowel syndrome: a systematic review … doi:10.1097/MEG.0000000000003062 PubMed
2. [2] Roman Maslennikov et al.. J Clin Med. 2026. Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome. doi:10.3390/jcm15031152 PubMed
3. [3] Marion Lenoir et al.. Probiotics Antimicrob Proteins. 2025. An 8-Week Course of Bifidobacterium longum 35624® Is Associated with a Reduction in the Symptoms of Irritable Bowel Syndrome. doi:10.1007/s12602-023-10151-w PubMed
4. [4] Arezina Kasti et al.. Microorganisms. 2025. The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review. doi:10.3390/microorganisms13010171 PubMed
5. [5] Maria Raffaella Barbaro et al.. Int J Mol Sci. 2025. A Probiotic Mixture of Lactobacillus rhamnosus LR 32, Bifidobacterium lactis BL 04, and Bifidobacterium longum BB 536 Counteracts the Increase … doi:10.3390/ijms26062656 PubMed
6. [6] Alexander Bertuccioli et al.. Front Med (Lausanne). 2025. Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11. doi:10.3389/fmed.2025.1604319 PubMed
7. [7] Francois-Pierre Martin et al.. Gut Microbes. 2024. Metabolome-associated psychological comorbidities improvement in irritable bowel syndrome patients receiving a probiotic. doi:10.1080/19490976.2024.2347715 PubMed
8. [8] Malwina Naghibi et al.. Nutrients. 2024. Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, and Intestinal Microbiota in Healthy Adults: A Randomised, … doi:10.3390/nu16223952 PubMed
9. [9] Guangyu Ma et al.. Microbiol Spectr. 2024. Effect of probiotic administration during pregnancy on the functional diversity of the gut microbiota in healthy pregnant women. doi:10.1128/spectrum.00413-24 PubMed
10. [10] Young Hoon Chang et al.. J Neurogastroenterol Motil. 2024. Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study. doi:10.5056/jnm23036 PubMed
11. [11] Anita Gąsiorowska et al.. J Clin Med. 2024. Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel … doi:10.3390/jcm14010006 PubMed
12. [12] Sylvia Cruchet Muñoz et al.. Nutrients. 2024. Effects of Bifidobacterium longum 35624 in Children and Adolescents with Irritable Bowel Syndrome. doi:10.3390/nu16121967 PubMed
13. [13] S Srivastava et al.. Gut Microbes. 2024. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated … doi:10.1080/19490976.2024.2338322 PubMed
14. [14] Han Chen et al.. J Transl Med. 2023. Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data. doi:10.1186/s12967-023-03953-7 PubMed
15. [15] Xueli Jin et al.. Food Funct. 2023. Selenium-enriched Bifidobacterium longum DD98 relieves irritable bowel syndrome induced by chronic unpredictable mild stress in mice. doi:10.1039/d2fo03408e PubMed
16. [16] David Groeger et al.. Neurogastroenterol Motil. 2023. Interactions between symptoms and psychological status in irritable bowel syndrome: An exploratory study of the impact of a probiotic combination. doi:10.1111/nmo.14477 PubMed
17. [17] Xin-Hui Khoo et al.. J Gastroenterol Hepatol. 2023. The impact of diet and ethnicity on gut microbiota variation in irritable bowel syndrome: A multi-center study. doi:10.1111/jgh.16174 PubMed
18. [18] O I Solovyeva et al.. Ter Arkh. 2023. [Long-term probiotic administration for irritable bowel syndrome: a legal need]. doi:10.26442/00403660.2023.08.202378 PubMed
19. [19] V N Drozdov et al.. Vopr Pitan. 2023. [Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea … doi:10.33029/0042-8833-2023-92-4-92-103 PubMed
20. [20] Jean-Marc Sabaté et al.. World J Gastroenterol. 2022. Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome. doi:10.3748/wjg.v28.i7.732 PubMed
21. [21] Seung Yong Shin et al.. J Neurogastroenterol Motil. 2022. Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: … doi:10.5056/jnm21202 PubMed
22. [22] Yae Jin Choi et al.. J Microbiol Biotechnol. 2022. Immunomodulatory Effects of Bifidobacterium spp. and Use of Bifidobacterium breve and Bifidobacterium longum on Acute Diarrhea in Children. doi:10.4014/jmb.2206.06023 PubMed
23. [23] Yuya Nakamura et al.. Comput Struct Biotechnol J. 2022. Integrated gut microbiome and metabolome analyses identified fecal biomarkers for bowel movement regulation by Bifidobacterium longum BB536 supplementation: A RCT. doi:10.1016/j.csbj.2022.10.026 PubMed
24. [24] Edgar Torres-Maravilla et al.. Sci Rep. 2022. Serpin-positive Bifidobacterium breve CNCM I-5644 improves intestinal permeability in two models of irritable bowel syndrome. doi:10.1038/s41598-022-21746-8 PubMed
25. [25] E P Yakovenko et al.. Ter Arkh. 2022. [The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel … doi:10.26442/00403660.2022.02.201368 PubMed
26. [26] Luisa Marras et al.. Microorganisms. 2021. The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia. doi:10.3390/microorganisms9040836 PubMed
27. [27] Cristina Iribarren et al.. Nutrients. 2021. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel … doi:10.3390/nu13113836 PubMed
28. [28] Francesco Di Pierro et al.. Clin Nutr ESPEN. 2021. Bifidobacterium longum W11: Uniqueness and individual or combined clinical use in association with rifaximin. doi:10.1016/j.clnesp.2020.12.025 PubMed
29. [29] E V Shikh et al.. Vopr Pitan. 2021. [Prospects of probiotic strains of bifidobacteria and enterococcus in treatment and prevention of diseases in gastroenterology]. doi:10.33029/0042-8833-2021-90-2-15-25 PubMed
30. [30] Selina R Cox et al.. Gastroenterology. 2020. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease … doi:10.1053/j.gastro.2019.09.024 PubMed
31. [31] Leonilde Bonfrate et al.. Eur J Clin Invest. 2020. Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients. doi:10.1111/eci.13201 PubMed
32. [32] Barbara Skrzydło-Radomańska et al.. Nutrients. 2020. The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant … doi:10.3390/nu12071999 PubMed
33. [33] Erin D Lewis et al.. Nutrients. 2020. Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in Alleviating Symptoms of Irritable Bowel Syndrome (IBS): A Randomized, Placebo-Controlled … doi:10.3390/nu12041159 PubMed
34. [34] Chunhua Zhou et al.. Gut Microbes. 2020. Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation. doi:10.1080/19490976.2020.1782156 PubMed
35. [35] Gian Paolo Caviglia et al.. J Clin Med. 2020. Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum … doi:10.3390/jcm9082353 PubMed
36. [36] Berkeley N Limketkai et al.. Cochrane Database Syst Rev. 2020. Probiotics for induction of remission in Crohn's disease. doi:10.1002/14651858.CD006634.pub3 PubMed
37. [37] Paola Vitellio et al.. Nutrients. 2019. Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients with Lactose Intolerance and Persisting Functional Gastrointestinal Symptoms: … doi:10.3390/nu11040886 PubMed
38. [38] Z F Ma et al.. Benef Microbes. 2019. Bifidobacterium infantis M-63 improves mental health in victims with irritable bowel syndrome developed after a major flood disaster. doi:10.3920/BM2018.0008 PubMed
39. [39] Afifa Ait-Belgnaoui et al.. J Neurogastroenterol Motil. 2018. Bifidobacterium longum and Lactobacillus helveticus Synergistically Suppress Stress-related Visceral Hypersensitivity Through Hypothalamic-Pituitary-Adrenal Axis Modulation. doi:10.5056/jnm16167 PubMed
40. [40] Ya-Nan Cao et al.. Saudi J Gastroenterol. 2018. Lactobacillus acidophilus and Bifidobacterium longum supernatants upregulate the serotonin transporter expression in intestinal epithelial cells. doi:10.4103/sjg.SJG_333_17 PubMed
41. [41] Carrie A M Wegh et al.. J Clin Gastroenterol. 2018. Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review. doi:10.1097/MCG.0000000000001054 PubMed
42. [42] Chase Meyer et al.. Gastroenterology. 2018. The Fragility of Probiotic Bifidobacterium longum NCC3001 Use for Depression in Patients With Irritable Bowel Syndrome. doi:10.1053/j.gastro.2017.09.055 PubMed
43. [43] Maria Ines Pinto-Sanchez et al.. Gastroenterology. 2017. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. doi:10.1053/j.gastro.2017.05.003 PubMed
44. [44] Amy R Romijn et al.. Aust N Z J Psychiatry. 2017. A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression. doi:10.1177/0004867416686694 PubMed
45. [45] Fuqiang Yuan et al.. Curr Med Res Opin. 2017. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis. doi:10.1080/03007995.2017.1292230 PubMed
46. [46] Emma P Halmos. J Gastroenterol Hepatol. 2017. When the low FODMAP diet does not work. doi:10.1111/jgh.13701 PubMed
47. [47] Andrew P Allen et al.. Curr Med Res Opin. 2017. Bifidobacterium infantis 35624 and other probiotics in the management of irritable bowel syndrome. Strain specificity, symptoms, and mechanisms. doi:10.1080/03007995.2017.1322571 PubMed
48. [48] Friedrich Altmann et al.. PLoS One. 2016. Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™. doi:10.1371/journal.pone.0162983 PubMed
49. [49] Qiao-Yan Gu et al.. Artif Cells Nanomed Biotechnol. 2016. Role of NLRP3 inflammasome in Bifidobacterium longum-regulated visceral hypersensitivity of postinfectious irritable bowel syndrome. doi:10.3109/21691401.2015.1111238 PubMed
50. [50] Jun Sik Yoon et al.. J Gastroenterol Hepatol. 2014. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. doi:10.1111/jgh.12322 PubMed
51. [51] János Fehér et al.. Orv Hetil. 2014. [Correlation of the microbiota and intestinal mucosa in the pathophysiology and treatment of irritable bowel, irritable eye, and irritable mind … doi:10.1556/OH.2014.29987 PubMed
52. [52] María Ortiz-Lucas et al.. Rev Esp Enferm Dig. 2013. Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis. doi:10.4321/s1130-01082013000100005 PubMed
53. [53] Bong Ki Cha et al.. J Clin Gastroenterol. 2012. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, … doi:10.1097/MCG.0b013e31823712b1 PubMed
54. [54] Libera Fanigliulo et al.. Acta Biomed. 2006. Role of gut microflora and probiotic effects in the irritable bowel syndrome. PubMed